SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-073770
Filing Date
2024-06-14
Accepted
2024-06-14 17:00:05
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4379
  Complete submission text file 0000950170-24-073770.txt   6051
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANELIXIS THERAPEUTICS, INC. 1500 DISTRICT AVENUE BURLINGTON MA 01803
Business Address
Perrin Steven (Reporting) CIK: 0001824545 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36620 | Film No.: 241045724